Skip to main content
. 2022 Oct 22;11(11):1456. doi: 10.3390/antibiotics11111456
HIFM Hollow-Fiber Infection Model
CAZ-AVI Ceftazidime-avibactam
CI Continuous infusion
Css steady-state concentrations
XDR PA extensively drug-resistant Pseudomonas aeruginosa
MIC minimum inhibitory concentration
ICU Intensive Care Unit
WGS Whole genome sequencing
GFR Glomerular filtration rate
CFU Colony-forming unit